Evidence map›Paper›PMID 40033280›Full record

SynthesisBMC psychiatry2025

Prevalence of major depressive disorder in Iranian men from 2011 to 2022; a systematic review and meta-analysis.

Ahmad Hajebi, Ilia Zamani Hajiabadi, Afsaneh Fendereski, Robabeh Ghodssighassemabadi, Arshia Zamani Hajiabadi, Jalil Hosseini, Keshvar Samadaee Gelehkolaee

Abstract readMeta-AnalysisSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ahmad HajebiResearch Center for Addiction & Risky Behaviors (ReCARB), Psychosocial Health Research Institute, Iran University of Medical Sciences, Tehran, Iran.
Ilia Zamani HajiabadiStudent research committee, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
Afsaneh FendereskiDepartment of biostatistics, School of Health, Mazandaran University of Medical Sciences, Sari, Iran.
Robabeh GhodssighassemabadiOffice of Biostatistics and Epidemiology, Université Paris- Saclay, Gustave Roussy, U1018, Inserm, Villejuif, 948 05, France.
Arshia Zamani HajiabadiStudent research committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Jalil HosseiniMen's Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Keshvar Samadaee GelehkolaeeMen's Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. k-samadaee@alumnus.tums.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMajor depressive disorder (MDD) is one of the health problems that imposes a large disease burden on the community. Its prevalence is based on gender. Therefore, this study aims to investigate the prevalence of MDD in Iranian men between 2011 and 2022.

methodsThe Medline, Embase, Scopus, Web of Sciences, PsycINfo, and Iranian databases were searched for studies published from January 2011 to December 2022. Two independent reviewers screened the observational studies conducted on men aged 15 years and older with MDD. The interested outcomes were the prevalence type of MDD.

resultsData of 5 studies were included in the present meta-analysis. Among 10,667 participants in the study, 1479 (13.9%) individuals had a history of MDD. In the subgroup analysis, the average lifetime prevalence was 7.6% (95% confidence interval [CI]; 4.7 - 12.0%) and the point prevalence was 19.1% (95% confidence interval [CI]; 6.7 - 43.5%) based on random effect model. The 12-month prevalence was 10.8% (95% confidence interval [CI]; 9.8 - 11.9%) based on the single study.

conclusionPreventive and therapeutic programs are strongly recommended due to the high prevalence of major depression in Iranian men and the lack of sufficient studies in this field.

Indexed as

Major Depressive DisorderAdultHumansIranMalePrevalenceA systematic reviewIranMajor depressive disorderMenPrevalence

Identifiers

PMID40033280
PMCPMC11874079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.